mito-extra® - medac GmbH
mito-extra® - medac GmbH
mito-extra® - medac GmbH
Erfolgreiche ePaper selbst erstellen
Machen Sie aus Ihren PDF Publikationen ein blätterbares Flipbook mit unserer einzigartigen Google optimierten e-Paper Software.
15 LITERATURVERZEICHNIS<br />
Albarran J, Imbert L<br />
Les Tumeurs de Rein<br />
Paris: Masson et Cie: 1903 452-459<br />
Ali-El-Dein B, Nabeeh A, El-Baz M, et al.<br />
Single-dose versus multiple instillations of epirubicin as prophylaxis for recurrence<br />
after transurethral resection of pTa and pT1 transitional-cell bladder tumours: a<br />
prospective, randomized controlled study<br />
Br-J-Urol 1997; 79: 731-735<br />
Au JLS, Badalament RA, Wientjes MG, Young DC, Warner JA, Venema PL,<br />
Pollifrone DL, Harbrecht JD, Chin J, Lerner SP, Miles BJ<br />
Methods to improve efficacy of intravesical Mitomycin: results of a randomized<br />
phase III trial<br />
J-Nat-Cancer-Inst; 2001, 93,8: 597-604<br />
Ausfeld R, Beer M, Mühlethaler JP, et al.<br />
Adjuvant intravesical chemotherapy of superficial bladder cancer with monthly<br />
Doxorubicin or intensive Mitomycin<br />
Eur-Urol 1987; 13: 10-14<br />
AWMF: ARBEITSGEMEINSCHAFT DER WISS. MED. FACHGESELLSCHAFTEN<br />
Leitlinien der Deutschen Krebsgesellschaft; Harnblasenkarzinom 2002, 3. Auflage<br />
http://www.uni-duesseldorf.de/WWW/AWMF/ll/032-038.htm<br />
Baselli EC, Greenberg RE<br />
Maintenance Therapy for superficial bladder cancer<br />
Oncology, 2001; 15: 85-91<br />
Bassi P, Iafrate M, Longo F, Ianello A, Mostaccio G, Ingrassia A, Repele M,<br />
Tavolini IM<br />
Intracavitary Therapy of Noninvasive transitional Cell Carcinoma of the Upper<br />
Urinary Tract<br />
Urol-Int 2001; 67: 189-194<br />
Beretta G, Cartei G, Giraldi T.<br />
Mitomycin. Pharmacology and Clinical Trials<br />
Minerva Medica Publishers 1990<br />
Berufsgenossenschaft für Gesundheitsdienst und Wohlfahrtspflege<br />
Merkblatt M620 Sichere Handhabung von Zytostatika 2000<br />
Bird V, Soloway M, Malmström PU.<br />
Intravesical chemotherapy in the treatment of supersicial bladder cancer.<br />
In Droller M ed. Bladder cancer : Current diagnosis and Treatment. Chapt 8.<br />
Tatowa NJ, USA: Humana Press Inc 2001: 183-223<br />
Blute ML, Segura JW, Patterson DE, Benson RC Jr, Zincke H.<br />
Impact of endourology on diagnosis and management of upper urinary tract urothelial<br />
cancer.<br />
J Urol. 1989 Jun;141(6):1298-301.<br />
Boccardo F, Cannata D, Rubagotti A, Guarneri D, Decensi-A et al.<br />
Prophylaxis of superficial bladder cancer with <strong>mito</strong>mycin or interferon Alfa-2b:<br />
Results of a multicentric italian study<br />
J-Clin-Oncol 1994; 12 (1): 7-13<br />
Böhle A, Jocham D, Bock PR<br />
Intravesical Bacillus-Calmette-Guerin versus Mitomycin for superficial bladder<br />
cancer: A formal meta-analysis of comparative studies on recurrence and toxicity<br />
J-Urol 2003; 169: 90 - 95<br />
57
Change language